https://www.idival.org/wp-content/uploads/2022/05/cab-presentacion.jpg

New study reveals genetic causes of patients with reduced phosphorus levels

20 de April de 2023

The research team from IDIVAL, HUMV and Sierrallana Hospital indicates that the results could help to prescribe the appropriate treatment and prevent complications. Identifying the causes of the decrease in the concentration of phosphorus in the blood was the main objective of the study carried out by the research team belonging to the Marqués de […]

Read more →

IDIVAL’s PRIM-VAL call for research projects in primary care is now open

10 de April de 2023

Applications may be submitted until 10 May at the following link   The PRIM-VAL call seeks to promote IDIVAL’s primary care research and innovation by partially or fully funding projects developed in this field. Project requirements Research and innovation projects will be considered on topics related to the field of primary care, preferably patient care, […]

Read more →

IDIVAL researchers explain the origin of COVID-19 headache and diarrhoea, two of the most frequent symptoms of this infection

This study sheds light on the processes that cause these ailments and possible future treatments. A research team from the Marqués de Valdecilla Health Research Institute (IDIVAL) and the Marqués de Valdecilla University Hospital (HUMV) has demonstrated the involvement of a molecule, a peptide known as CGRP, in COVID-19 infection, specifically in headache and diarrhoea, […]

Read more →

The Nanomedicine Group of IDIVAL designs a new gene transfer system based on nanotechnology

5 de April de 2023

The biocompatibility, stability and reproducibility of this novel method allows its industrial production for uses such as personalized therapy.  The Nanomedicine Group of the Marqués de Valdecilla Health Research Institute (IDIVAL) has designed and optimized a novel method based on nanoparticles capable of encapsulating, storing and transferring genetic material into cells. The procedure is easily […]

Read more →

The 13th Quality and Patient Safety Conference will be held in Santander on 3 and 4 May 2023. An open and participative discussion forum in which the patient safety culture is promoted and good practices carried out in healthcare centres are shared. These conferences have been held for many years in Cantabria and have been […]

Read more →

Conference: Advances in digital transformation: incorporating the use of data into healthcare. 16th March

13 de March de 2023

This Thursday, 16 March, the conference “Advances in digital transformation: incorporating the use of data into healthcare” will take place at the Marqués de Valdecilla University Hospital. The conference, focused on the opportunities of the use of Big Data and its applicability in healthcare environments, is organised by the IDIVAL Research Institute and sponsored by […]

Read more →

Next Progress Session

6 de March de 2023

The 8th March we will have the presentations of Javier Isaac Lera Torres and Rebeca Abajas Bustillo, within the Progress Reports Valdecilla programme. The session will be held in the Innovation and User Experience Laboratory – Linnux at 14:00 hours, and will be broadcast live on the Zoom platform. HEALTH TECHNOLOGY ASSESSMENT (HTA) FROM A […]

Read more →

4th edition of the Neurology update course. Neurology in Primary Care

On 14, 15 and 16 March the 4th edition of the course “Update in neurology. Neurology in Primary Care” directed by Manuel Delgado Alvarado and Javier Riancho Zarrabeitia, neurologists at Sierrallana Hospital. During the course the main neurological problems will be reviewed with a practical approach. Course limited to 25 places, last places available. Registration […]

Read more →

Valdecilla-IDIVAL participates in a study that discovers blood biomarkers that could predict the onset of symptoms in a genetic Parkinson’s subtype

Researchers from the IDIVAL neurodegenerative diseases group and the Movement Disorders Unit of the Marqués de Valdecilla University Hospital (HUMV) have participated in a recent study, promoted by the Clínic Barcelona-IDIBAPS, which has detected alterations in the expression profile of four microRNAs, which could make it possible to detect the onset of genetic Parkinson’s disease […]

Read more →

Cantabria participates in Care4Diabetes, an EU project to improve care for people with type II diabetes

2 de March de 2023

Care4Diabetes aims to empower patients to take an active role in the management of their disease. Endocrinologist Luis Alberto Vazquez Salví took part in the project’s inaugural conference held on 16 and 17 February in Oviedo with all the partners involved in Care4Diabetes. The aim is to implement in the European Union the Reverse Diabetes2 […]

Read more →